How Does the FDA Ensure the Safety of Antiviral Drugs?
The FDA evaluates antiviral drugs through clinical trials to ensure their safety and efficacy before granting approval. The agency continuously monitors these drugs post-approval to identify any adverse effects. The FDA's post-market surveillance systems, such as the FDA Adverse Event Reporting System (FAERS), play a critical role in detecting any safety issues that may arise after the drugs are widely used.
